$449.81 Million in Sales Expected for Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) This Quarter

Equities research analysts forecast that Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) will report sales of $449.81 million for the current fiscal quarter, Zacks Investment Research reports. Eight analysts have provided estimates for Allscripts Healthcare Solutions’ earnings, with estimates ranging from $446.48 million to $453.00 million. Allscripts Healthcare Solutions reported sales of $535.80 million in the same quarter last year, which would suggest a negative year-over-year growth rate of 16%. The company is expected to issue its next quarterly earnings report on Thursday, November 7th.

According to Zacks, analysts expect that Allscripts Healthcare Solutions will report full year sales of $1.79 billion for the current fiscal year, with estimates ranging from $1.78 billion to $1.82 billion. For the next fiscal year, analysts expect that the firm will post sales of $1.87 billion, with estimates ranging from $1.84 billion to $1.90 billion. Zacks’ sales averages are a mean average based on a survey of research analysts that follow Allscripts Healthcare Solutions.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last released its quarterly earnings data on Thursday, August 8th. The software maker reported $0.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.16 by $0.01. Allscripts Healthcare Solutions had a net margin of 9.85% and a return on equity of 6.17%. The company had revenue of $444.50 million during the quarter, compared to analyst estimates of $449.03 million. During the same quarter in the prior year, the business earned $0.18 earnings per share. The business’s quarterly revenue was up .7% compared to the same quarter last year.

Several research firms have recently issued reports on MDRX. BidaskClub raised shares of Allscripts Healthcare Solutions from a “strong sell” rating to a “sell” rating in a research report on Wednesday, September 11th. ValuEngine lowered shares of Allscripts Healthcare Solutions from a “hold” rating to a “sell” rating in a research report on Friday, July 26th. TheStreet lowered shares of Allscripts Healthcare Solutions from a “c-” rating to a “d+” rating in a research report on Tuesday, August 13th. Jefferies Financial Group began coverage on shares of Allscripts Healthcare Solutions in a research report on Friday, August 23rd. They issued a “buy” rating and a $13.00 price objective for the company. Finally, Robert W. Baird set a $13.00 price objective on shares of Allscripts Healthcare Solutions and gave the stock a “buy” rating in a research report on Monday, August 12th. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $12.36.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. ETF Managers Group LLC boosted its stake in Allscripts Healthcare Solutions by 9.7% during the 1st quarter. ETF Managers Group LLC now owns 11,589 shares of the software maker’s stock valued at $111,000 after acquiring an additional 1,028 shares during the last quarter. Glen Harbor Capital Management LLC boosted its stake in Allscripts Healthcare Solutions by 7.7% during the 2nd quarter. Glen Harbor Capital Management LLC now owns 17,504 shares of the software maker’s stock valued at $204,000 after acquiring an additional 1,248 shares during the last quarter. Tyers Asset Management LLC boosted its stake in Allscripts Healthcare Solutions by 7.7% during the 2nd quarter. Tyers Asset Management LLC now owns 24,068 shares of the software maker’s stock valued at $280,000 after acquiring an additional 1,716 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in Allscripts Healthcare Solutions by 16.9% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 12,460 shares of the software maker’s stock valued at $145,000 after acquiring an additional 1,800 shares during the last quarter. Finally, Riverhead Capital Management LLC boosted its stake in Allscripts Healthcare Solutions by 7.5% during the 2nd quarter. Riverhead Capital Management LLC now owns 27,330 shares of the software maker’s stock valued at $318,000 after acquiring an additional 1,900 shares during the last quarter.

Shares of Allscripts Healthcare Solutions stock traded up $0.51 during trading hours on Wednesday, hitting $10.90. The company’s stock had a trading volume of 2,075,156 shares, compared to its average volume of 1,439,791. Allscripts Healthcare Solutions has a 1-year low of $8.54 and a 1-year high of $14.47. The business has a fifty day moving average of $9.57 and a 200 day moving average of $10.18. The company has a market capitalization of $1.73 billion, a PE ratio of 19.82, a P/E/G ratio of 2.02 and a beta of 1.38. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.70.

Allscripts Healthcare Solutions Company Profile

Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions.

See Also: What is the price-to-earnings growth (PEG) ratio?

Get a free copy of the Zacks research report on Allscripts Healthcare Solutions (MDRX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.